Shareholder uprising against PPD merger quelled by settlement
But not all investors are happy with agreement which allows $3.9 billion deal to proceedDespite objections from one institutional shareholder, the North Carolina Business Court has approved the settlement of a class action against Wilmington-based clinical research company Pharmaceutical Product Development Inc. and two private equity firms.
You have clicked on a link to
information that is
Already a paid subscriber but not registered for online access yet? For instructions on how to get premium web access, click here.
Interested in Subscribing?
Start by choosing how you'd like your news delivered.
- Print and Digital -
Try North Carolina Lawyers Weekly for a month
Published: June 15, 2012
Time posted: 4:47 pm